Abstract
Understanding disease burden is necessary to optimally distribute resources, direct research efforts, and prioritize healthcare interventions. The Global Burden of Disease (GBD) Study was established in 1990 with the goal of providing accurate, transparent data for all diseases across the globe. In order to measure disease burden, this study employs disability-adjusted life years (DALYs), a metric which incorporates mortality and burden of living with a disease into a single unit. This open access database includes data from 2010 covering 291 conditions, 1160 sequelae, and 67 risk factors across 187 countries, allowing a comprehensive assessment of the world’s health as a whole and evaluation of potential regional differences in disease burden. Overall, GBD 2010 demonstrated that skin conditions rank fourth in terms of non-fatal disease burden. Additionally, 8 skin disorders rank in the top 50 most prevalent diseases worldwide. This resource highlights the importance of skin disease internationally and serves as an important resource for further refining our understanding the role of cutaneous disorders in across diverse societal, cultural, and environmental contexts.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Chiang CL. An index of health: mathematical models. Vital Health Stat. 1965;1(94):1–19.
Chen MK. The gross national health product: a proposed population health index. Public Health Rep. 1979;94(2):119–23.
Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8.
Murray CL, Lopez AD, editors. Summary: Global Burden of Disease—a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health; 1996.
Murray CJ, Lopez AD, Wibulpolprasert S. Monitoring global health: time for new solutions. BMJ. 2004;329(7474):1096–100.
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349(9061):1269–76.
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436–42.
Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429–45.
Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223. Crucial landmark update of the original GBD study, which increased the number of conditions, sequelae, risk factors and countries included. This study also reanalyzed the original data from 1990 to allow more accurate comparison with new data.
Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–57.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–34. First study to look more critically and specifically at the dermatologic conditions included in the mass of GBD data.
Karimkhani C, Boyers LN, Margolis DJ, Naghavi M, Hay RJ, Williams HC, et al. Comparing cutaneous research funded by the national institute of arthritis and musculoskeletal and skin diseases with 2010 global burden of disease results. PLoS One. 2014;9(7):e102122.
Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, et al. Global burden of skin disease as reflected in Cochrane database of systematic reviews. JAMA Dermatol. 2014. doi:10.1001/jamadermatol.2014.709. Comparison of the burden of skin disease with the current research efforts using Cochrane reviews as a way to quantify research efforts. Allows comparison between what is causing people problems and what investigators are doing to fix these problems.
Boyers LN, Karimkhani C, Hilton J, Richheimer W, Dellavalle RP. Global burden of eye and vision disease as reflected in the Cochrane database of systematic reviews. JAMA Ophthalmol. 2014. doi:10.1001/jamaophthalmol.2014.3527.
About GBD. Institute for Health Metrics and Evaluation Web site. http://www.healthdata.org/gbd/about. Accessed July 14, 2014. Website contains open access to all GBD data and comparison of any subset of the data. This allows researchers or individuals access to their wealth of data to promote new interpretations of the data.
Karimkhani C, Boyers LN, Naghavi M, Coffeng LE, Lott JP, Wulf S, et al. The global burden of disease associated with alopecia areata. Br J Dermatol. 2014. doi:10.1111/bjd.13559.
Compliance with Ethics Guidelines
Conflict of Interest
K Goff, LN Boyers, C Karimkhani, JP Lott, and RP Dellavalle all declare no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Epidemiology
Rights and permissions
About this article
Cite this article
Goff, K., Boyers, L.N., Karimkhani, C. et al. Disease Burden Measures: a Review. Curr Derm Rep 4, 30–35 (2015). https://doi.org/10.1007/s13671-014-0094-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13671-014-0094-x